Diabetic foot ulcer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients meeting the diagnostic criteria of diabetic foot; 2. Patients with IDSA grade 2; 3. Culture confirmed the bacteriological basis, and the wound was infected by drug-resistant bacteria; 4. Patients with HbA1c = 0.4; 7. Patients with wound area between 1 cm x 1cm and 10 cm x 10cm; 8. Patients who voluntarily participated in the trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients allergic to compound Phellodendron solution and silver ion antibacterial dressing; 2. Patients who used antibiotics in any way within one week before treatment; 3. Serious heart, liver and kidney dysfunction, which seriously affect the safety and treatment of the subjects, should be ruled out by the researchers; 4. Patients with foot ulcer caused by venous, tumor, radiation, simple arterial and other non-diabetic reasons. 5. Patients with serum albumin < 25g / L; 6. Patients with hemoglobin < 90g / L; 7. Patients whose platelets are lower than the lower limit of normal value; 8. Subjects with pregnancy or birth planning, or pregnant or lactating women; 9. Patients with cognitive impairment can not give full informed consent; 10. Patients with allergic constitution or known hypersensitivity to the components of test drug and control drug; 11. Patients who participated in other clinical trials in recent one month; 12. According to the judgment of the researcher, the patient was unable to complete the study or comply with the requirements of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the proportion of resoluting infection;the time of resoluting infection; | — |
Countries
China
Contacts
Dongzhimen Hospital, Beijing University of Chinese Medicine